Home  >  News
Eppen_Cent_Feb24
you can get e-magazine links on WhatsApp. Click here
News
  Aadi Bioscience announces publication of long-term efficacy and safety data further supporting Fyarro to treat malignant PEComa,   March 04, 2024
  Cyient partners with MassMedic to accelerate MedTech innovation,   March 04, 2024
  IPGA forms Jharkhand state committee,   March 04, 2024
  Kenvue collaborates with API to unveil expert recommendations on cough evaluation & management at APICON 2024,   March 04, 2024
  Aeon MD Dr A P Vaitheeswaran passes away,   March 04, 2024
  Pharmacy Associations join forces to advocate for pharmacists during change healthcare outage,   March 04, 2024
  TechInvention Lifecare announces the ground breaking of its state-of-the-art GCMC,   March 04, 2024
  Jaslok Hospital partnered HSBC Bombay Gymkhana 10K Run as medical partner,   March 04, 2024
  Global Care Consulting facilitates historic healthcare agreement to establish Mongolia's first- ever comprehensive cardiac sciences centre of excellence,   March 04, 2024
  SynaptixBio awarded second US FDA Orphan Drug Designation to boost search for rare disease therapies,   March 04, 2024
  FLAME University hosts IDMA's Annual Conference: vriddhi 2024 towards shaping the future of the Indian pharma industry,   March 04, 2024
  National Institute for Health and Care Research welcomes launch of Rare Disease Action Plan 2024,   March 04, 2024
  Ayush-ICMR Advanced Centre for Integrated Health Research launched in AIIMS,   March 04, 2024
  Indira IVF, BD SurePath join hands to advance cervical cancer screening in India,   March 04, 2024
  China NMPA approves CARsgen's NDA for zevorcabtagene autoleucel to treat relapsed or refractory multiple myeloma,   March 04, 2024
  Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients,   March 04, 2024
  NIH researchers identify new antibodies targeting “dark side” of influenza virus protein,   March 04, 2024
  US FDA approves J&J’s Rybrevant in combo with chemotherapy for patients with NSCLC with EGFR exon 20 insertion mutations,   March 04, 2024
  US FDA approves Boston Scientific’s AGENT Drug-Coated Balloon,   March 04, 2024
  Centre announces commissioning of bulk drugs and medical devices projects under PLI schemes,   March 04, 2024

 Back
 
CEI_CPT_CLI_150x60
Pharma_India_Expo24
India Lab Expo
Copyright © 2023 Saffron Media Pvt. Ltd |